Bristol Orencia Pharmacovigilance Plan Sufficient For Approval, Committee Says
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's Arthritis Drugs Advisory Committee unanimously recommends approval of the rheumatoid arthritis therapy abatacept.